MED13 and congenital heart disease: In children with congenital heart disease, blood samples show a significant increase in the editing rate of the Alu element region within intron 9 of the mediator complex subunit 13 (MED13) gene, accompanied by decreased ADAR2 expression, suggesting a potential link between aberrant editing and congenital heart disease [424].